company news release. The study, published in the journal Science on Aug. 12, noted that antibodies created by Moderna’s COVID-19 vaccine were able to provide continued protection against the virus six months after patients received their second dose. "We are pleased with these new data showing that people vaccinated with two doses of the Moderna COVID-19 vaccine maintained antibodies through six months, including against variants of concern such as the Delta variant.